头部和部瘤学的最新进展 - - 当前的知识和未来的视野
Camil Ciprian Mirestean1, Roxana Irina Iancu2,3, Dragos Petru Teodor Iancu1,2
1Regional Institute of Oncology, Iasi, Romania.
Maedica
|February 20, 2025
概括
免疫检查点抑制剂是复发性/转移性头支状细胞癌 (HNSCC) 的标准,但存活率仍然很差. 需要新的策略,如抗体-药物联合体和组合疗法,以获得更好的头癌治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 头部和部癌症研究研究
背景情况:
- 免疫检查点抑制剂 (ICI) 是复发性/转移性头支状细胞癌 (HNSCC) 的标准治疗方法.
- 尽管取得了进展,但高级HNSCC的存活率在四年内仍然低于20%.
- 目前的治疗方法,包括EGFR抑制剂和化疗,具有局限性,需要新的方法.
研究的目的:
- 对先进的HNSCC.审查当前的治疗标准.
- 突出现有治疗方法的局限性,包括ICI单疗法.
- 探索新兴的治疗策略和HNSCC的未来方向.
主要方法:
- 对HNSCC (EXTREME,TPex) 的当前治疗方案的审查.
- 用ICI治疗的患者的生存数据的分析.
- 识别和讨论正在研究的新疗法模式.
主要成果:
- ICI已经取代了旧的方案,但提供了有限的长期生存益处.
- 在晚期HNSCC患者中,只有不到20%的患者存活超过4年.
- 组合疗法和新药具有前景,但需要进一步的临床评估.
结论:
- 对于HNSCC来说,除了PD1/PD-L1阻塞之外,还需要更有效的疗法.
- 抗体-药物合物,疫苗,双特异性抑制剂和TME调节剂是有希望的未来战略.
- 研究新的治疗序列,包括新辅助化疗和mTOR抑制剂,对于改善局部发达,复发或转移性HNSCC的结果至关重要.
更多相关视频
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Arteries of the Head and Neck
999
The human body's intricate network of arteries ensures that every organ system receives the necessary oxygen and nutrients for optimal function. The arterial network in the head and neck region is particularly complex, providing vital blood flow to the brain, eyes, and other critical structures. Prominent arteries in this region include the internal carotid arteries and the vertebral arteries.
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
999
Veins of Head and Neck
1.2K
The blood drainage from the head and neck is primarily managed by three pairs of veins: the external jugular, internal jugular, and vertebral veins. The external jugular veins drain superficial scalp and face structures, passing over the sternocleidomastoid muscles to empty into the subclavian veins.
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
1.2K
Cancer Vaccines
327
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
327


